CER TEK BIO ProJECTS 2025

At Cer Tek Bio Corp, our drug discovery platform focuses on identifying breakthrough therapeutics targeting mucosal pathogens and diseases lacking effective treatments. We prioritize candidates based on validated biology and leverage novel delivery technologies to accelerate development timelines. Each therapeutic is advanced through a structured translational pathway designed to optimize clinical relevance, safety, and scalability.

Our biomedical engineering team creates practical, elegant interfaces between humans and advanced biological systems. This includes diagnostic hardware for remote settings, robotic assistive devices, and user-friendly clinical tools. Our focus is on function, simplicity, and seamless integration into real-world environments to improve both patient and provider outcomes.

We engineer microbial strains to express therapeutic proteins and immune-modulating molecules with precision and purpose. Using CRISPR and modular cloning systems, we insert and optimize genes for high expression and biosafety. Our workflows ensure that every engineered strain is tailored for stability, effectiveness, and compliance with regulatory standards.

Cer Tek Bio develops microbial production systems capable of efficient and sustainable biosynthesis. We design fermentation processes to scale cleanly, with minimal waste, and focus on modular designs that support adaptive manufacturing goals. Our industrial platform bridges innovation in synthetic biology with operational reliability for global bioproduction.

Our bioinformatics pipeline integrates AI-driven structural prediction with pathogen surveillance and immune-system modeling. We identify surface-expressed antigens and rank them based on evolutionary pressure, immunogenic potential, and delivery compatibility. This data-centric strategy informs every design decision, from antigen selection to vector development.